Hypoxia-Inducible factor 1 alpha inhibitor
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | <StructureSection load='1h2m' size='340' side='right' caption='Structure of | + | <StructureSection load='1h2m' size='340' side='right' caption='Structure of FIH-1 dimer (green, grey) complex with HIF-1 C-terminal transactivation domain (dark khaki), oxalylglycine, sulphate and Zn+2 ion (grey) (PDB code [[1h2m]])' scene=''> |
== Function == | == Function == |
Revision as of 08:13, 23 February 2021
|
3D Structures of Hypoxia-Inducible factor 1 alpha inhibitor
Updated on 23-February-2021
References
- ↑ Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001 Oct 15;15(20):2675-86. PMID:11641274 doi:http://dx.doi.org/10.1101/gad.924501
- ↑ Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, Fontana M, Moon JC, Pinzani M, Gillmore JD, Hawkins PN, Pepys MB. Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. N Engl J Med. 2015 Sep 17;373(12):1106-14. doi: 10.1056/NEJMoa1504942. Epub 2015 , Jul 15. PMID:26176329 doi:http://dx.doi.org/10.1056/NEJMoa1504942
- ↑ Hohenester E, Hutchinson WL, Pepys MB, Wood SP. Crystal structure of a decameric complex of human serum amyloid P component with bound dAMP. J Mol Biol. 1997 Jun 20;269(4):570-8. PMID:9217261 doi:10.1006/jmbi.1997.1075